이오플로우
294090KOSDAQ의료용 기기 제조업56.9 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
EoFlow is a medical device company established in 2011, specializing in wearable insulin pumps using electroosmotic pump technology. It launched the disposable wearable insulin pump EOPatch in 2021, which offers superior convenience, waterproofing, and longer replacement intervals compared to existing products, securing a competitive edge in the diabetes medical device market. The company expanded into European markets in 2022 and is exploring diverse fields such as obesity and NASH treatments through non-insulin pump business. However, its non-insulin business has been halted due to a lawsuit with Insulet.
Number of Employees
51people
Average Salary
55.0M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Avg ▼25.4% (2-year basis)
Avg ▲4.3% (2-year basis)
Avg ROE -140.2% (declining, 2yr)
Detailed News Sentiment
- Positive[인터뷰] 박성민 큐어스트림 대표 “국내 최초 재사용 패치형 인슐린.....
이오플로우의 혁신적인 재사용 패치형 인슐린 펌프 '모두스트림'이 식약처 품목허가를 획득하며 시장 진출을 앞두고 있어 긍정적인 전망을 제공합니다.
- Neutral'인슐린펌프 춘추전국시대'…케어메디·이오플로우·큐어스트림 격돌
국내 패치형 인슐린펌프 시장 경쟁 심화로 인해 이오플로우의 위치 변화에 대한 시장 반응은 제한적.
Detailed Momentum
52w mid range (50%)
1m 0% (flat)
Volume flat
Detailed Disclosure
- Neutral기타시장안내 (개선계획서 제출)2026-07-22
- Neutral기타시장안내 (상장적격성 실질심사 대상 결정)2026-06-30
- Neutral주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)2026-06-30
